These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 18359706

  • 21. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response.
    Novak MJ, Smythies LE, McPherson SA, Smith PD, Morrow CD.
    Vaccine; 1999 May 14; 17(19):2384-91. PubMed ID: 10392620
    [Abstract] [Full Text] [Related]

  • 22. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge.
    Harbour SN, Every AL, Edwards S, Sutton P.
    Helicobacter; 2008 Dec 14; 13(6):494-9. PubMed ID: 19166414
    [Abstract] [Full Text] [Related]

  • 23. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA, Stensson A, Schön K, Lycke N.
    Scand J Immunol; 2006 Feb 14; 63(2):97-105. PubMed ID: 16476008
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K, Shiota S, Yamada K, Gotoh K, Suganuma M, Fujioka T, Ahmed K, Iha H, Nishizono A.
    Helicobacter; 2009 Oct 14; 14(5):135-43. PubMed ID: 19751439
    [Abstract] [Full Text] [Related]

  • 25. Systemic immune responses to oral administration of recombinant attenuated Salmonella typhimurium expressing Helicobacter pylori urease in mice.
    Liu XF, Hu JL, Quan QZ, Sun ZQ, Wang YJ, Qi F.
    World J Gastroenterol; 2005 Apr 14; 11(14):2154-6. PubMed ID: 15810083
    [Abstract] [Full Text] [Related]

  • 26. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W, Wu W, Xu X.
    Vaccine; 2007 Nov 01; 25(44):7664-73. PubMed ID: 17913305
    [Abstract] [Full Text] [Related]

  • 27. [Evaluation of immune prophylaxis of recombinant urease subunit of Helicobacter pylori].
    Shi L, Wang J, Chen Y.
    Zhonghua Yi Xue Za Zhi; 2000 Nov 01; 80(11):811-5. PubMed ID: 11218872
    [Abstract] [Full Text] [Related]

  • 28. A plasmid immunization construct encoding urease B of Helicobacter pylori induces an antigen-specific antibody response and upregulates the expression of beta-defensins and IL-10 in the stomachs of immunized mice.
    Hatzifoti C, Bajaj-Elliott M, Dorrell N, Anyim M, Prentice MB, Nye KE, Wren B, Morrow WJ.
    Vaccine; 2004 Jun 30; 22(20):2651-9. PubMed ID: 15193391
    [Abstract] [Full Text] [Related]

  • 29. Therapeutic vaccination against Helicobacter pylori infection with attenuated recombinant Salmonella typhimurium urease B subunit and catalase in mice.
    Li GQ, Chen MH, Zhu SL, Chen J, Jiao ZY, Chen W, Hu PJ.
    Chin J Dig Dis; 2004 Jun 30; 5(2):72-5. PubMed ID: 15612661
    [Abstract] [Full Text] [Related]

  • 30. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model.
    Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, Bouzourene H, Michetti P.
    Gastroenterology; 2009 Jun 30; 136(7):2237-2246.e1. PubMed ID: 19272385
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Liu KY, Shi Y, Luo P, Yu S, Chen L, Zhao Z, Mao XH, Guo G, Wu C, Zou QM.
    Vaccine; 2011 Sep 02; 29(38):6679-85. PubMed ID: 21745524
    [Abstract] [Full Text] [Related]

  • 32. Immunogenicity of Helicobacter pylori urease B protein and DNA vaccines in a mouse model.
    Bégué RE, Cruz AR, Ramgoolam A, Breslin MB.
    J Pediatr Gastroenterol Nutr; 2007 Oct 02; 45(4):493-6. PubMed ID: 18030223
    [Abstract] [Full Text] [Related]

  • 33. Screening and identification of a novel B-cell neutralizing epitope from Helicobacter pylori UreB.
    Li HX, Mao XH, Shi Y, Ma Y, Wu YN, Zhang WJ, Luo P, Yu S, Zhou WY, Guo Y, Wu C, Guo G, Zou QM.
    Vaccine; 2008 Dec 09; 26(52):6945-9. PubMed ID: 18948159
    [Abstract] [Full Text] [Related]

  • 34. Novel methods of quantitative real-time PCR data analysis in a murine Helicobacter pylori vaccine model.
    Roussel Y, Harris A, Lee MH, Wilks M.
    Vaccine; 2007 Apr 12; 25(15):2919-29. PubMed ID: 16905224
    [Abstract] [Full Text] [Related]

  • 35. [Construction of attenuated Salmonella typhimurium vaccine strain expressing Helicobacter pylori catalase and observation on its protective immunity].
    Liao W, Chen M, Zhu S.
    Zhonghua Yi Xue Za Zhi; 2001 May 25; 81(10):613-6. PubMed ID: 11798935
    [Abstract] [Full Text] [Related]

  • 36. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X, Xing Y, Guo L, Lv X, Song H, Xi T.
    Pathog Dis; 2014 Oct 25; 72(1):78-86. PubMed ID: 24687988
    [Abstract] [Full Text] [Related]

  • 37. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
    Flach CF, Svensson N, Blomquist M, Ekman A, Raghavan S, Holmgren J.
    Vaccine; 2011 Feb 01; 29(6):1235-41. PubMed ID: 21147129
    [Abstract] [Full Text] [Related]

  • 38. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice.
    Lee MH, Roussel Y, Wilks M, Tabaqchali S.
    Vaccine; 2001 Jul 16; 19(28-29):3927-35. PubMed ID: 11427267
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P, Doidge C, Pinczower G, Wilson J, Harbour S, Swierczak A, Lee A.
    FEMS Immunol Med Microbiol; 2007 Jul 16; 50(2):213-9. PubMed ID: 17567282
    [Abstract] [Full Text] [Related]

  • 40. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
    Kubota E, Joh T, Tanida S, Sasaki M, Kataoka H, Watanabe K, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Yamada T, Mori Y, Fujita F, Shimura T, Ohara H, Isaka M, Yasuda Y, Itoh M.
    Helicobacter; 2005 Aug 16; 10(4):345-52. PubMed ID: 16104951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.